Is Sapporo Clinical stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Sapporo Clinical pays dividends. Last time was Sunday 1st of June 2025 where the investors holding the stock on Friday 28th of March 2025 were paid JPY23 per share. Over the last 23 times between 2000 and 2025, Sapporo Clinical has paid JPY271 with an average of JPY11.78 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Sapporo Clinical 10 years ago, but if you had invested on Friday 22nd of November 2019 when the price was JPY1 820.00, you would have made a loss of JPY-848.00 per share or -46.59%
No, the average daily trading liquidity for Sapporo Clinical is JPY632 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.
Sapporo Clinical has little of the business financed by loans. This puts the company at lower risk in periods of high inflation where borrowing costs usually go up. The company has a very low net profit margin of 2.18%, which is challenging.
We have calculated the inflation risk for Sapporo Clinical to be low [0.5 of 1]
US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.